icometrix NV
About icometrix NV
icometrix NV is a leading healthcare AI company specializing in advanced software solutions for the quantitative analysis of brain MRI and CT scans. Their flagship platform, icobrain, provides physicians with objective and clinically meaningful data to support the diagnosis, monitoring, and treatment of a wide range of neurological disorders. This includes conditions such as Multiple Sclerosis (MS), dementia (including Alzheimer’s disease), traumatic brain injury (TBI), epilepsy, stroke, and Parkinson’s disease. The AI-powered tools quantify subtle changes in brain structures, lesion load, and atrophy over time, offering critical insights that complement traditional radiological readings and enhance data-driven clinical decision-making.
For medical professionals, icometrix’s solutions are designed to integrate seamlessly into existing workflows, providing FDA-cleared and CE-marked reports. Notable products include icobrain ms for visualizing changes in multiple sclerosis and icobrain aria, the first FDA-cleared AI solution for detecting and quantifying amyloid-related imaging abnormalities (ARIA), which are crucial for monitoring patients on amyloid-targeting therapies for Alzheimer’s. Beyond neuroimaging, icometrix also developed icolung for AI-driven lung analyses during the COVID-19 pandemic and icompanion, a digital platform for MS patients to track their health. The company’s technology is utilized in hundreds of hospitals globally and is also a partner for pharmaceutical companies in clinical trials and drug development.
Focus Areas
Business Intelligence
| Key Investors | Capricorn Partners, KU Leuven, UZA, Forestay Capital, Optum Ventures, HERAN Partners |
| Partnerships | GE HealthCare (acquisition), American College of Radiology (ACR), DENT Neurologic Institute, Philips, Siemens Healthineers, Nuance, Micron, Guerbet, DocPanel, Aidoc, Affidea, AstraZeneca, VITO, Barco |
| Acquisitions | Acquired by GE HealthCare (September 12, 2025) |
| Technology | Cloud-based AI solution, deep-learning-based AI algorithms, icobrain platform, icobridge for secure data transfer and interoperability with PACS and EMR systems. Utilizes technologies such as Kubernetes, MySQL, and TypeScript. |
| FDA Clearances | Multiple. Key clearances include initial FDA clearance for icobrain in 2015-2016, and icobrain aria, the first and only AI software approved for detecting, measuring, and grading amyloid-related imaging abnormalities (ARIA) in November 2024. cleared products (estimated) |
What Physicians Need to Know
For physicians, icometrix NV stands out by transforming complex brain imaging scans into clear, actionable, and quantitative insights, enabling data-driven clinical decision-making. Their AI solutions significantly improve diagnostic sensitivity and accuracy, particularly in detecting subtle changes and critical abnormalities like ARIA, while reducing subjective manual analysis and processing time. The FDA-cleared status of solutions like icobrain aria provides confidence in their clinical utility, especially for monitoring patients on new amyloid-targeting therapies. Furthermore, the integration with major imaging vendors ensures a streamlined workflow, and the icompanion app facilitates enhanced patient monitoring and engagement, ultimately supporting personalized and efficient neurological care. The company also provides evidence of cost-effectiveness and supports reimbursement efforts, such as CPT III code reimbursement in the US.
icometrix NV's solutions are designed for seamless integration into existing clinical workflows. Their platform is being integrated with GE HealthCare's MRI systems and deep learning offerings (e.g., AIR xu2122 Brain, AIR Recon DL, SONIC DL 3D) for optimized workflows. They also integrate with Philips' BlueSeal MR scanners and healthcare informatics platform, including Philips cloud-based AI Manager, to provide an end-to-end solution for acquiring, reading, and reporting MRI brain scans. This multi-vendor compatibility ensures broad accessibility and ease of adoption within diverse healthcare environments.
What the Web Says
Icometrix NV is a Belgian MedTech company specializing in AI-powered brain MRI analysis and neurological disease quantification. Their flagship product, icobrain, provides automated quantitative analysis of brain scans for conditions like multiple sclerosis, Alzheimer's disease, and traumatic brain injury. The company is recognized for its strong technical expertise, industry specialization in neurological imaging, and regulatory clearances (FDA and CE marking) for its platform.
Overall: PositiveStrengths
- Exceptional technical expertise in deep learning applied to medical imaging.
- High industry specialization in neurological imaging.
- Regulatory clearances (FDA and CE) provide confidence for hospital procurement and clinical adoption.
- Demonstrated real-world scalability and reliability with 200+ hospital deployments.
- Academic pedigree ensures innovation grounded in peer-reviewed research.
- AI-driven, validated, and FDA-cleared solutions assist radiologists and neurologists with comparing and quantifying brain MRI scans over time.
Limitations
- Narrow vertical focus, which may not suit organizations looking for a broader medical AI partner.
- Premium pricing structure, potentially a barrier for smaller clinics and regional healthcare providers.
Based on reviews from: SectorPunk, Elion, Icometrix (company website), Philips and icometrix (press release)
Last updated: 2026-07-18
Videos
News, demos, and interviews about icometrix NV.
Videos load interactively. If none appear, search YouTube for icometrix NV →
Press & Coverage
Frequently Asked Questions
Related Companies
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]
Healthcare Finance.AI is a company dedicated to leveraging cutting-edge artificial intelligence to optimize healthcare revenue cycles. Their goal is to improve financial outcomes for healthcare providers while simultaneously supporting the industry’s commitment to quality care and efficiency. They aim to achieve this by enhancing healthcare finance through AI innovation, demonstrating increased revenue cycle efficiency, reducing […]
The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]
Imperial College Business School is a global business school that is part of Imperial College London, a top-ranking science-based institution. Established in 2004, the school integrates business and entrepreneurship with technology. Its roots in business education trace back to 1955 with an operational research/management science course. The school is triple-crown accredited (AACSB, AMBA, EQUIS), placing […]
Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]